The five essential pieces of financial paperwork you must never lose

Mislaying key documents can cause real headaches, so it’s worth tracking down these most commonly-lost bits of paperwork

Lineage Cell Therapeutics, Inc. (LCTX)

NYSE American - NYSE American Delayed price. Currency in USD

Add to watchlist

1.1400

0.0000

(0.00%)

At close: 04:00PM EDT

1.1600

+0.02

(+1.75%)

After hours:

07:55PM EDT

Currency in USD

Earnings estimate	Current qtr. (Mar 2024)	Next qtr. (Jun 2024)	Current year (2024)	Next year (2025)
No. of analysts	6	6	6	5
Avg. Estimate	-0.04	-0.04	-0.11	-0.13
Low estimate	-0.05	-0.05	-0.22	-0.23
High estimate	-0.02	-0.03	-0.01	-0.03
Year ago EPS	-0.03	-0.03	-0.12	-0.11

Revenue estimate	Current qtr. (Mar 2024)	Next qtr. (Jun 2024)	Current year (2024)	Next year (2025)
No. of analysts	6	6	6	5
Avg. Estimate	1.36M	1.12M	17.48M	17.49M
Low estimate	N/A	N/A	N/A	2.6M
High estimate	3.59M	3.65M	45M	50M
Year ago sales	2.01M	3.23M	8.95M	17.48M
Sales growth (year/est)	-32.30%	-65.30%	95.40%	0.10%

Earnings history	30/03/2023	29/06/2023	29/09/2023	30/12/2023
Est. EPS	-0.04	-0.04	-0.04	-0.04
Actual EPS	-0.03	-0.03	-0.04	-0.03
Difference	0.01	0.01	0	0.01
Surprise %	25.00%	25.00%	0.00%	25.00%

EPS trend	Current qtr. (Mar 2024)	Next qtr. (Jun 2024)	Current year (2024)	Next year (2025)
Current estimate	-0.04	-0.04	-0.11	-0.13
7 days ago	-0.04	-0.04	-0.11	-0.13
30 days ago	-0.04	-0.04	-0.12	-0.13
60 days ago	-0.04	-0.05	-0.12	-0.1
90 days ago	-0.04	-0.05	-0.12	-0.1

EPS revisions	Current qtr. (Mar 2024)	Next qtr. (Jun 2024)	Current year (2024)	Next year (2025)
Up last 7 days	N/A	N/A	N/A	N/A
Up last 30 days	N/A	N/A	N/A	N/A
Down last 7 days	N/A	N/A	N/A	N/A
Down last 30 days	N/A	N/A	N/A	N/A

Growth estimates	LCTX	Industry	Sector(s)	S&P 500
Current qtr.	-33.30%	N/A	N/A	N/A
Next qtr.	-33.30%	N/A	N/A	N/A
Current year	8.30%	N/A	N/A	N/A
Next year	-18.20%	N/A	N/A	N/A
Next 5 years (per annum)	N/A	N/A	N/A	N/A
Past 5 years (per annum)	N/A	N/A	N/A	N/A